Search for:
Category

Singapore

Category

The Singapore Court of Appeal, in its recent decision of Reed, Michael v Bellingham, Alex (Attorney-General, intervener) [2022] SGCA 60, provides clarity on two provisions under the Personal Data Protection Act (PDPA). The first is section 4(1)(b), which states that the PDPA does not impose any obligation on any employee acting in the course of their employment with an organization. The second is the then section 32 (now section 48O), which allows individuals who suffer loss or damage as a result of an organization’s contravention of the PDPA, the right to commence private action against the organization.

With the coming into force of the Corporate Registers (Miscellaneous Amendments) Act 2022 on 4 October 2022, the Companies Act 1967 and the Limited Liability Partnerships Act 2005 have been amended to subject nominee shareholders and their nominators and individuals with “executive control” over the daily or regular corporate affairs to new disclosure obligations. This further aligns Singapore’s regime on transparency and beneficial ownership of Singapore-incorporated companies, foreign companies and limited liability partnerships with the international standards set by the Financial Action Task Force.

The Code of Practice: Chief Executives’ and Board of Directors’ Workplace Safety and Health Duties will, when gazetted in October 2022, apply to all directors and equivalent officers involved in policy making and executive decisions for business affairs of companies in all industries, even for companies which have no manual work and little risk of physical injury.

On 13 September 2022, the Health Sciences Authority (HSA) issued a retail-level recall in respect of a therapeutic product found to contain foreign matter. Earlier this month, the HSA also issued an update on products found and reported by overseas regulators to contain potent ingredients, and briefly explained the possible side effects of the potent ingredients.

On 2 September 2022, the Singapore Ministry of Health announced that additional transitional support will be provided to cancer patients with changes introduced to the financing regime of cancer drugs.
Subsidies of clinically effective and cost effective cancer drugs will, with effect from 1 September 2022, be extended through the Medication Assistance Fund at Public Healthcare Institutions.
Additional transitional support will also be implemented to cushion the impact of cancer drug spending for patients with IPs that currently cover their treatments and patients with MediShield Life only.

On 30 August 2022, the Indonesian House of Representatives agreed to pass a law ratifying the Regional Comprehensive Economic Partnership, the largest regional free trade agreement outside the World Trade Organization — involving 10 ASEAN countries and five non-ASEAN countries, i.e., China, New Zealand, Australia, Japan and South Korea. With the passing of this law, which still requires promulgation by the President, RCEP is set to come into force for Indonesia, possibly before the end of the year.

The Ministry of Health (MOH) will be introducing “Nutri-Grade”-related measures that will apply to freshly prepared beverages. From the end of 2023, all outlets selling freshly prepared beverages with higher sugar and saturated fat content will have to label such beverages with the “Nutri-Grade” mark. Outlets will also be prohibited from advertising freshly prepared beverages with the highest level of sugar and saturated fat content.